Abstract
In 68 men with benign prostatic hyperplasia, we evaluated the association between obesity and prostatic enlargement, as well as changes in serum levels of oestradiol, testosterone, dihydroepiandrosterone and dihydroepiandrosterone sulphate. Despite the larger adenomas, no increase in the symptom score for BPH was observed with increasing obesity. Average specimen weights increased with increasing obesity and increasing host age from 46 to 80 g. We also found the serum oestradiol level significantly elevated in obese men who were 140% or over recommended weight compared to underweight men younger than 60 years (51.3 pg/ml versus 26.8 pg/ml, p<0.01). This pattern was present in all age groups.
These results indicate that obesity is a risk factor for prostatic enlargement but not for obstruction. Also the degree of obesity appears to have a direct effect on oestradiol levels through transformation of androgens in adipose tissue to oestrogens. In conclusion, further studies to evaluate the pathogenesis, pathophysiology, natural history and symptomatology of BPH would be of great interest and should help to define better the associations that we have recognized.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Walsh, P. C.: Benign prostatic hyperplasia. In: Walsh, P. C., Retik, A. B., Stamey, T. A., Vaughan, E. D. Jr. (eds). Campbell's Urology, 6th ed. Saunders, Philadelphia 1992, pp. 1009–1028.
Barry, M. J.: Epidemiology and natural history of benign prostatic hyperplasia.Urol. Clin. North Am., 17, 495 (1990).
Coffey, D. S., Walsh, P. C.: Clinical and experimental study of benign prostatic hyperplasia.Urol. Clin. North Am., 17, 461 (1990).
Schneider, G., Kirschner, M. A., Berkowitz, R., Ertel, N. H.: Increased estrogen production in obese men.J. Clin. Endocrinol. Metab., 48, 633 (1979).
Glynn, R. J., Campion, E. W., Bouchard, G. R., Silbert, J. F.: Coronary risk factors and plasma sex hormones.Amer. J. Med., 73, 648 (1982).
Bray, G. A., Classification and evaluation of the obesity.Med. Clin. North Am., 73, 161 (1989).
Narayan, P., Neoplasms of prostate gland. In: Tanagho, E. A., Mc Aninch, J. W. (eds): Smith's General Urology, 13th ed Appleton Lange, Connecticut 1992, pp. 378–412.
Matzkin, H., Soloway, M. S.. Cigarette smoking: A review of possible associations with benign prostatic hyperplasia and prostate cancer.Prostate, 22, 277 (1993).
Mc Neal, J.: Pathology of benign prostatic hyperplasia.Urol. Clin. North Am., 17, 477 (1990).
Daniell, H. V.: Larger prostatic adenomas in obese men with no associated increase in obstructive uropathy.J. Urol., 149, 315 (1993).
Grayhack, J. T., Kozlowski, J. M., Benign prostatic hyperplasia In: Gillenwater, J. Y., Grayhack, J. T., Howards, S. S., Duckett, J.W. (eds). Adult and Pediatric Urology, 2nd ed. Mosby Yearbook Inc., St. Louis 1992, pp. 1211–1277.
Harbitz, T. B., Haugen, O. A.: Histology of the prostate in elderly men.Acta Pathol. Microbiol. Immunol. Scand. (A),80, 756 (1972).
Caine, M.: The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy.J. Urol., 136, 1 (1986).
Mc Neal, J. E.: The zonal anatomy of the prostate.Prostate, 2, 35 (1991).
Mc Neal, J. E.: The prostate gland: Morphology and pathology,Monogr. Urol., 4, 3 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soygür, T., Küpeli, B., Aydos, K. et al. Effect of obesity on prostatic hyperplasia: Its relation to sex steroid levels. International Urology and Nephrology 28, 55–59 (1996). https://doi.org/10.1007/BF02550138
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02550138